| Edward W Chang, MD | |
|
401 Bicentennial Way, Santa Rosa, CA 95403-2149 | |
| (707) 571-4000 | |
| Not Available |
| Full Name | Edward W Chang |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 30 Years |
| Location | 401 Bicentennial Way, Santa Rosa, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528146008 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | A67940 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced Phase 3 study results for linagliptin 5 mg once-daily, which showed significant hemoglobin A1c (HbA1c or A1C) reduction of 0.88 percent compared to 0.24 percent in the placebo group (p=0.0002) at 24 weeks in black or African American adult patients with type 2 diabetes whose blood sugar was not adequately controlled.
Body mass index (BMI) during infancy may help to predict if a child will be obese by age four. In a study focused on the infant BMI-childhood obesity relationship in a cohort with a majority of African-American children, researchers from The Children's Hospital of Philadelphia say that a better understanding of infant growth patterns may lead to more effective early efforts at obesity prevention.
Nearly two-thirds of men and women age 80 and older have high blood pressure, but their conditions are frequently not kept under control, according to new data from the National Heart, Lung, and Blood Institute's (NHLBI) long-standing Framingham Heart Study.
Biotechnology Innovation Organization President & CEO James C. Greenwood today issued the following statement on the United States-Mexico-Canada Agreement (USMCA):
› Verified 4 days ago
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced Phase 3 study results for linagliptin 5 mg once-daily, which showed significant hemoglobin A1c (HbA1c or A1C) reduction of 0.88 percent compared to 0.24 percent in the placebo group (p=0.0002) at 24 weeks in black or African American adult patients with type 2 diabetes whose blood sugar was not adequately controlled.
Body mass index (BMI) during infancy may help to predict if a child will be obese by age four. In a study focused on the infant BMI-childhood obesity relationship in a cohort with a majority of African-American children, researchers from The Children's Hospital of Philadelphia say that a better understanding of infant growth patterns may lead to more effective early efforts at obesity prevention.
Nearly two-thirds of men and women age 80 and older have high blood pressure, but their conditions are frequently not kept under control, according to new data from the National Heart, Lung, and Blood Institute's (NHLBI) long-standing Framingham Heart Study.
Biotechnology Innovation Organization President & CEO James C. Greenwood today issued the following statement on the United States-Mexico-Canada Agreement (USMCA):
› Verified 4 days ago
| Entity Name | Ritvik Mehta Md, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538302997 PECOS PAC ID: 8022163286 Enrollment ID: O20090911000428 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced Phase 3 study results for linagliptin 5 mg once-daily, which showed significant hemoglobin A1c (HbA1c or A1C) reduction of 0.88 percent compared to 0.24 percent in the placebo group (p=0.0002) at 24 weeks in black or African American adult patients with type 2 diabetes whose blood sugar was not adequately controlled.
Body mass index (BMI) during infancy may help to predict if a child will be obese by age four. In a study focused on the infant BMI-childhood obesity relationship in a cohort with a majority of African-American children, researchers from The Children's Hospital of Philadelphia say that a better understanding of infant growth patterns may lead to more effective early efforts at obesity prevention.
Nearly two-thirds of men and women age 80 and older have high blood pressure, but their conditions are frequently not kept under control, according to new data from the National Heart, Lung, and Blood Institute's (NHLBI) long-standing Framingham Heart Study.
Biotechnology Innovation Organization President & CEO James C. Greenwood today issued the following statement on the United States-Mexico-Canada Agreement (USMCA):
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Edward W Chang, MD 1800 Harrison St Fl 7, Oakland, CA 94612-3466 Ph: (510) 625-6262 | Edward W Chang, MD 401 Bicentennial Way, Santa Rosa, CA 95403-2149 Ph: (707) 571-4000 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced Phase 3 study results for linagliptin 5 mg once-daily, which showed significant hemoglobin A1c (HbA1c or A1C) reduction of 0.88 percent compared to 0.24 percent in the placebo group (p=0.0002) at 24 weeks in black or African American adult patients with type 2 diabetes whose blood sugar was not adequately controlled.
Body mass index (BMI) during infancy may help to predict if a child will be obese by age four. In a study focused on the infant BMI-childhood obesity relationship in a cohort with a majority of African-American children, researchers from The Children's Hospital of Philadelphia say that a better understanding of infant growth patterns may lead to more effective early efforts at obesity prevention.
Nearly two-thirds of men and women age 80 and older have high blood pressure, but their conditions are frequently not kept under control, according to new data from the National Heart, Lung, and Blood Institute's (NHLBI) long-standing Framingham Heart Study.
Biotechnology Innovation Organization President & CEO James C. Greenwood today issued the following statement on the United States-Mexico-Canada Agreement (USMCA):
› Verified 4 days ago
Dr. William Arnold Combs, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1701 4th St Ste 120, Santa Rosa, CA 95404 Phone: 707-523-7025 | |
Dr. Victor G Lacombe, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1002 Mendocino Ave, Santa Rosa, CA 95401 Phone: 707-577-8292 Fax: 707-575-3941 | |
Stefan M Zechowy, M.D. Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: 1701 4th St, Ste 120, Santa Rosa, CA 95404 Phone: 707-523-7025 Fax: 707-523-3024 | |
Annick Aubin-pouliot, Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: 1701 4th St Ste 120, Santa Rosa, CA 95404 Phone: 707-523-7025 Fax: 707-523-3024 | |
Dr. Richard Turley, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 401 Bicentennial Way, Santa Rosa, CA 95403 Phone: 707-393-4409 | |
Charles J. Meltzer, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 401 Bicentennial Way, Santa Rosa, CA 95403 Phone: 707-571-4000 | |
Mark R Homicz, M.D. Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: 1701 4th St Ste 120, Santa Rosa, CA 95404 Phone: 707-523-7025 Fax: 707-523-3024 |